This page was generated by AI. It is not a source of trustworthy medical information.
The curated page (written by a real person) is here
other ai pages: allergy | comments | criteria | disability | epidem | fake | genetics | hain_criteria | hearing | hydrops | lermoyez | menieres | migraine | mri-hydrops | new_rx | path | proposed | references | vestibular_atelectasis
Delayed endolymphatic hydrops (DEH) is a condition characterized by an abnormal buildup of fluid within the inner ear, specifically in the endolymphatic spaces. The term "delayed" refers to the typically long interval between an initial severe inner ear injury and the later onset of episodic vertigo. DEH is often discussed alongside Meniere's disease, as both share the same underlying pathophysiological feature: endolymphatic hydrops. However, DEH is distinguished by a history of profound unilateral hearing impairment that precedes the vertigo episodes by months or years.
Endolymphatic hydrops describes a condition in which the membranous labyrinth of the inner ear becomes distended due to an excess of endolymphatic fluid. This excess fluid is thought to result from an imbalance between production and absorption of endolymph. When pressures become elevated, the delicate structures responsible for hearing and balance may be disturbed, leading to symptoms such as hearing loss, tinnitus, fullness or pressure in the ear, and attacks of vertigo. Meniere's disease is the classic disorder associated with endolymphatic hydrops, and it typically produces fluctuating hearing loss and recurrent vertigo in the affected ear.
In delayed endolymphatic hydrops, patients almost always have a history of a severe, often sudden, hearing loss in one ear. This initial loss may have occurred years earlier, sometimes in childhood or as a result of viral infection, trauma, or other inner ear damage. After a prolonged symptom-free interval, the individual begins experiencing episodes of vertigo that are clinically similar to those seen in Meniere's disease. The key distinction is the prior severe hearing impairment. In Meniere's disease, vertigo and hearing loss typically occur together or at least within the same active phase of disease. In DEH, the hearing loss is established before the vertigo attacks ever appear.
DEH is classified into two forms:
Individuals with DEH experience spontaneous episodes of rotatory vertigo that may last from twenty minutes to several hours. They may also suffer from imbalance, nausea, and vomiting during an acute attack. Unlike Meniere's disease, where pressure or fullness in the ear is a common warning symptom, many DEH patients do not notice aural fullness before vertigo begins. The previously damaged ear is usually profoundly deaf or has only residual hearing, so new auditory symptoms such as tinnitus or worsened hearing are not always reported. In the contralateral form, the better ear may show fluctuating hearing, tinnitus, and a feeling of fullness, resembling more typical Meniere's disease symptoms.
The precise cause of delayed endolymphatic hydrops remains unclear, but it is believed that the original insult to the inner ear somehow alters the normal fluid-regulating mechanisms. The resulting chronic imbalance in endolymph pressure may eventually lead to hydrops and subsequent vertigo attacks. Risk factors often mentioned include previous viral labyrinthitis, head injury, ear surgery, or sudden sensorineural hearing loss of unknown origin. There is no strong evidence that heredity plays a major role in DEH. In cases related to Meniere's disease, researchers consider DEH a distinct clinical entity rather than a straightforward variant of Meniere's, although the underlying hydrops unites both conditions.
Diagnosis of DEH relies on a careful medical history and clinical evaluation. The key clue is a documented episode of severe unilateral hearing loss preceding the onset of vertigo by a significant interval. Audiometric testing is essential to confirm the degree and pattern of hearing loss. Imaging studies, such as magnetic resonance imaging (MRI), may be used to rule out other structural causes of vertigo, such as vestibular schwannoma or other tumors. Electrocochleography and vestibular evoked myogenic potentials are sometimes employed as supportive tests for the presence of hydrops, though they cannot definitively diagnose DEH by themselves. A response to treatments that reduce endolymphatic pressure may support the diagnosis indirectly.
There is no cure for delayed endolymphatic hydrops, but treatment aims to reduce vertigo disability and preserve residual hearing in the unaffected ear. Management is largely modeled on therapy for Meniere's disease. Initial measures include dietary changes, particularly a low-sodium diet, and the use of diuretic agents to lower fluid retention. About one-half to two-thirds of patients may achieve acceptable vertigo control with these conservative measures. Avoiding caffeine and alcohol may also be helpful for some individuals.
For patients who continue to have disabling vertigo despite conservative therapy, more directed interventions may be considered. Intratympanic corticosteroid injections can be administered into the middle ear to reduce inflammation and alter fluid balance. Another procedure involves the administration of intratympanic gentamicin, an antibiotic that is ototoxic to balance function, thereby chemically ablating the overactive vestibular hair cells in the affected ear. This treatment is effective in reducing vertigo attacks but carries a risk of further hearing loss, which is an important consideration when treating the only hearing ear in contralateral DEH.
Surgical options exist for severe, unrelenting cases. Endolymphatic sac decompression or shunting is sometimes performed, although its long-term efficacy remains debated. More definitive procedures, such as vestibular nerve section or labyrinthectomy, are reserved for patients with incapacitating vertigo and negligible useful hearing in the affected ear. Labyrinthectomy is generally not an option for contralateral DEH because it would destroy the only functional balance and hearing organ on one side, and therefore a vestibular nerve section is typically preferred in that scenario.
The natural history of delayed endolymphatic hydrops is variable. Some patients gradually improve over years, and the frequency of vertigo attacks often diminishes with time. The unaffected ear in the ipsilateral form is generally at risk for developing contralateral involvement, with studies suggesting a rate of from a few percent to over a third of patients over many years. Prompt management of episodes and lifestyle adjustments can significantly improve quality of life. While DEH can be a disabling condition, most patients respond at least partially to conservative measures, and a comprehensive approach by an ear, nose, and throat specialist is essential.
Because delayed endolymphatic hydrops shares clinical features with Meniere's disease, support groups and education resources designed for people living with Meniere's and other balance disorders can be beneficial. Patients are often advised to keep a detailed symptom diary, identify potential triggers such as stress or dietary excess, and develop strategies for managing sudden vertigo episodes safely. Vestibular rehabilitation therapy may also help to improve balance and reduce the sense of disequilibrium between attacks.
Delayed endolymphatic hydrops is an important diagnostic consideration in any person who develops episodic vertigo long after a documented severe hearing loss. Although closely related to Meniere's disease through the common mechanism of endolymphatic hydrops, its clinical presentation and management have unique aspects. A thorough assessment to differentiate the ipsilateral and contralateral forms is essential for selecting the safest and most effective treatment. With appropriate medical and, when necessary, surgical care, most patients can obtain significant relief from the disruptive vertigo attacks that characterize this condition.
This page was generated by AI.
It is not a source of trustworthy medical information.
The curated page
see also: allergy | comments | criteria | disability | epidem | fake | genetics | hain_criteria | hearing | hydrops | lermoyez | menieres | migraine | mri-hydrops | new_rx | path | proposed | references | vestibular_atelectasis